- Moderna (MRNA) plans to request an Emergency Use Authorization (EUA) from U.S. Food and Drug Administration (FDA) and conditional approval from European Medicines Agency (EMA)
Market news
30 November 2020
Moderna (MRNA) plans to request an Emergency Use Authorization (EUA) from U.S. Food and Drug Administration (FDA) and conditional approval from European Medicines Agency (EMA)
- Company reaffirms that data analysis indicates a vaccine efficacy of 94.1%
Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerOpen Demo Account & Personal Page